Litcius/Paper detail

Is Apo-CIII the new cardiovascular target? An analysis of its current clinical and dietetic therapies

Lorenzo.G. de la Parra Soto, Janet A. Gutiérrez‐Uribe, Ashutosh Sharma, Aurea K. Ramírez‐Jiménez

2021Nutrition Metabolism and Cardiovascular Diseases19 citationsDOI

Topics & Concepts

Lipoprotein lipaseMedicineType 2 diabetesDiseaseApolipoprotein BBioinformaticsDiabetes mellitusTriglycerideLipid metabolismPharmacologyInternal medicineEndocrinologyBiochemistryEnzymeBiologyCholesterolDiabetes, Cardiovascular Risks, and LipoproteinsClusterin in disease pathologyLipid metabolism and disorders
Is Apo-CIII the new cardiovascular target? An analysis of its current clinical and dietetic therapies | Litcius